beta-lactams has been researched along with Soft Tissue Infections in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Cobian, J; Hall, B; Miller, J; Wilson, K | 1 |
| Doi, Y; Qureshi, ZA; Syed, A | 1 |
| Bowman, C; Charlett, A; Cookson, B; Davey, P; Fleet, E; Gopal Rao, G; Patel, B | 1 |
| Abdalla, AM; Abdelwahab, SF; Ahmed, EF; Gad, GF; Hasaneen, AM | 1 |
| Gardella, N; Grenon, S; Gutkind, G; Mollerach, M; Ubeda, C; von Specht, MH | 1 |
| Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
| Arguedas, A; Blumer, J; Botet, FA; Cespedes, J; Gesser, R; Snyder, T; Wang, J; West, J; Wimmer, W; Yogev, R | 1 |
| Elliott, DJ; Keren, R; Loh, A; Troxel, AB; Zaoutis, TE | 1 |
| Arrigucci, S; Mazzei, T; Novelli, A | 1 |
| Casas, CO; Fernández, FM; Guilera, ED; Guillen, VV; Salido, AJ; Tarragó, AC | 1 |
| DiNubile, MJ; Lipsky, BA | 1 |
| Almela, M; Brugal, MT; Castro, P; Caylà, JA; Coll, P; Colomés, JLL; de la Red, G; de Olalla, PG; Español, M; García, F; Gatell, JM; Libois, A; March, F; Romeu, J; Salvadó, M; Sambeat, MA; Sánchez, F; Sierra, JM; Vila, J | 1 |
| Falagas, ME; Matthaiou, DK; Vardakas, KZ | 1 |
3 review(s) available for beta-lactams and Soft Tissue Infections
| Article | Year |
|---|---|
[Pharmacodynamic and pharmacokinetic of antibiotics for treatment of skin and soft tissue infections].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Resistance, Bacterial; Fluoroquinolones; Glycopeptides; Humans; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; Tissue Distribution | 2009 |
Complicated infections of skin and skin structures: when the infection is more than skin deep.
Topics: Adult; Anti-Bacterial Agents; Bacteria, Anaerobic; beta-Lactams; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Lactams; Skin Diseases, Bacterial; Soft Tissue Infections | 2004 |
Fluoroquinolones vs beta-lactams for empirical treatment of immunocompetent patients with skin and soft tissue infections: a meta-analysis of randomized controlled trials.
Topics: Anti-Infective Agents; beta-Lactams; Fluoroquinolones; Humans; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Soft Tissue Infections | 2006 |
2 trial(s) available for beta-lactams and Soft Tissue Infections
| Article | Year |
|---|---|
Impact of implementation of a novel antimicrobial stewardship tool on antibiotic use in nursing homes: a prospective cluster randomized control pilot study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Female; Humans; Inappropriate Prescribing; Long-Term Care; Male; Nursing Homes; Pilot Projects; Practice Patterns, Physicians'; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Infectious; Soft Tissue Infections; Urinary Tract Infections | 2014 |
Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Ertapenem; Female; Humans; Infant; Male; Molecular Sequence Data; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Urinary Tract Infections | 2009 |
8 other study(ies) available for beta-lactams and Soft Tissue Infections
| Article | Year |
|---|---|
Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department.
Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Centers for Medicare and Medicaid Services, U.S.; Early Diagnosis; Early Medical Intervention; Emergency Service, Hospital; Female; Guideline Adherence; Hospital Mortality; Hospitalization; Humans; Male; Medical Overuse; Meropenem; Middle Aged; Patient Care Bundles; Piperacillin, Tazobactam Drug Combination; Reimbursement Mechanisms; Retrospective Studies; Sepsis; Shock, Septic; Soft Tissue Infections; Time-to-Treatment; United States; Urinary Tract Infections; Vancomycin | 2020 |
Safety and efficacy of long-term outpatient ertapenem therapy.
Topics: Adult; Aged; Arthritis, Infectious; beta-Lactams; Bone and Bones; Cohort Studies; Ertapenem; Follow-Up Studies; Humans; Intraabdominal Infections; Middle Aged; Outpatients; Pneumonia, Bacterial; Retrospective Studies; Skin; Soft Tissue Infections; Surgical Wound Infection; Treatment Outcome; Young Adult | 2014 |
Prevalence of methicillin resistant Staphylococcus aureus among Egyptian patients after surgical interventions.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Child; Child, Preschool; Egypt; Female; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Penicillin-Binding Proteins; Polymerase Chain Reaction; Prevalence; Soft Tissue Infections; Staphylococcal Infections; Wound Infection; Young Adult | 2014 |
Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in a pediatric hospital in Argentina.
Topics: Adolescent; Anti-Bacterial Agents; Argentina; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Hospitals, Pediatric; Humans; Infant; Longitudinal Studies; Male; Methicillin-Resistant Staphylococcus aureus; Molecular Typing; Soft Tissue Infections; Staphylococcal Skin Infections; Virulence Factors | 2014 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Child; Child, Preschool; Clindamycin; Cohort Studies; Drug Therapy, Combination; Emergency Service, Hospital; Empiricism; Female; Hospitalization; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Philadelphia; Retrospective Studies; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Streptococcal Infections; Streptococcus pyogenes; Treatment Failure; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2009 |
Spontaneous abscess of the anterior abdominal wall caused by Clostridium perfringens resistant to clindamycin.
Topics: Abdominal Abscess; Abdominal Pain; Abdominal Wall; Aged; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Clostridium Infections; Clostridium perfringens; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Soft Tissue Infections; Tomography, X-Ray Computed | 2012 |
Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003.
Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Middle Aged; Molecular Epidemiology; Mutation; Population Surveillance; Prospective Studies; Restriction Mapping; Retrospective Studies; Risk Factors; Sequence Analysis, DNA; Soft Tissue Infections; Spain; Streptococcal Infections; Streptococcus pyogenes; Substance Abuse, Intravenous | 2006 |